Roselie Achten

Long-term follow-up and treatment outcomes of conjunctivitis during dupilumab treatment in patients with moderate-to-severe atopic dermatitis

Roselie Achten, Daphne S. Bakker, Lieneke F.M. Ariëns et al. · The Journal of Allergy and Clinical Immunology In Practice · 2020 · 55 citations · Full text

Life Sciences, Dermatology, Immunology +16

Dupilumab‐associated ocular surface disease in atopic dermatitis patients: Clinical characteristics, ophthalmic treatment response and conjunctival goblet cell analysis

Roselie Achten, Judith L. Thijs, Marlot van der Wal et al. · Allergy · 2023 · 39 citations · Full text

Medicine, Dermatology, Ophthalmology +17

Identification of Risk Factors for Dupilumab-associated Ocular Surface Disease in Patients with Atopic Dermatitis

Roselie Achten, Chantal van Luijk, Lisa Van der Rijst et al. · Acta Dermato Venereologica · 2022 · 26 citations · Full text

Life Sciences, Dermatology, Immunology +13

Economic and Humanistic Burden in Paediatric Patients with Atopic Dermatitis

Roselie Achten, Lisa Van der Rijst, Marjanne A. Piena et al. · Acta Dermato Venereologica · 2023 · 17 citations · Full text

Medicine, Dermatology, Pediatrics +16

Association of Serum Dupilumab Levels at 16 Weeks With Treatment Response and Adverse Effects in Patients With Atopic Dermatitis

Lotte S. Spekhorst, Marlies de Graaf, Floris C. Loeff et al. · JAMA Dermatology · 2022 · 14 citations · Full text

Medicine, Dermatology, Pharmacotherapy +17